Literature DB >> 20812048

[Renal cell carcinoma: recent developments in diagnostics and therapy].

J Bedke1, A Stenzl.   

Abstract

This review highlights new strategies in the treatment of renal cell carcinoma (RCC). The benign or malignant status of renal masses in preoperative imaging as well as the detection of metastases and their differentiation from secondary malignancies is discussed. For the prognostic stratification of RCC the TNM system has been adopted. Nephron-sparing (NS) techniques of laparoscopy, radiofrequency and cryoablation are critically compared and the newest results of robotic-assisted (DaVinci) NS surgery are given. The special question of cytoreductive surgery in primary metastatic disease and the question of adjuvant immunotherapy are raised. New medical treatment strategies including new substances, vaccines and the possibility of sequential therapy are discussed.

Entities:  

Mesh:

Year:  2010        PMID: 20812048     DOI: 10.1007/s00120-010-2378-5

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  36 in total

1.  Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer.

Authors:  R C Flanigan; S E Salmon; B A Blumenstein; S I Bearman; V Roy; P C McGrath; J R Caton; N Munshi; E D Crawford
Journal:  N Engl J Med       Date:  2001-12-06       Impact factor: 91.245

2.  [Adjuvant autologous tumour cell vaccination in patients with renal cell carcinoma. Overall survival analysis with a follow-up period in excess of more than 10 years].

Authors:  M May; F Kendel; B Hoschke; C Gilfrich; S Kiessig; S Pflanz; M Seidel; S Brookman-Amissah
Journal:  Urologe A       Date:  2009-09       Impact factor: 0.639

3.  Robot-assisted partial nephrectomy: an international experience.

Authors:  Brian M Benway; Sam B Bhayani; Craig G Rogers; James R Porter; Nicolò M Buffi; Robert S Figenshau; Alexandre Mottrie
Journal:  Eur Urol       Date:  2010-01-22       Impact factor: 20.096

4.  Serial monitoring of circulating tumor cells predicts outcome of induction biochemotherapy plus maintenance biotherapy for metastatic melanoma.

Authors:  Kazuo Koyanagi; Steven J O'Day; Peter Boasberg; Michael B Atkins; He-Jing Wang; Rene Gonzalez; Karl Lewis; John A Thompson; Clay M Anderson; Jose Lutzky; Thomas T Amatruda; Evan Hersh; Jon Richards; Jeffrey S Weber; Dave S B Hoon
Journal:  Clin Cancer Res       Date:  2010-04-06       Impact factor: 12.531

5.  Perinephric and renal sinus fat infiltration in pT3a renal cell carcinoma: possible prognostic differences.

Authors:  Jens Bedke; Stephan Buse; Maria Pritsch; Stephan Macher-Goeppinger; Peter Schirmacher; Axel Haferkamp; Markus Hohenfellner
Journal:  BJU Int       Date:  2008-12-08       Impact factor: 5.588

6.  Pulmonary metastasis from renal cell carcinoma: characterization using contrast-enhanced CT attenuation value measurements.

Authors:  Dae Chul Jung; Hyuck Jae Choi; Hyae Young Kim; Kang Hyun Lee
Journal:  J Comput Assist Tomogr       Date:  2009 Jan-Feb       Impact factor: 1.826

7.  Technique of laparoscopic-endoscopic single-site surgery radical nephrectomy.

Authors:  Jens-Uwe Stolzenburg; Panagiotis Kallidonis; Giles Hellawell; Minh Do; Tim Haefner; Anja Dietel; Evangelos N Liatsikos
Journal:  Eur Urol       Date:  2009-06-23       Impact factor: 20.096

8.  Ten-year survival analysis for renal carcinoma patients treated with an autologous tumour lysate vaccine in an adjuvant setting.

Authors:  Matthias May; Sabine Brookman-May; Bernd Hoschke; Christian Gilfrich; Friederike Kendel; Susann Baxmann; Stefan Wittke; Stephan T Kiessig; Kurt Miller; Manfred Johannsen
Journal:  Cancer Immunol Immunother       Date:  2009-10-30       Impact factor: 6.968

9.  Comparison of whole-body MRI and bone scintigraphy in the detection of bone metastases in renal cancer.

Authors:  S A Sohaib; G Cook; S D Allen; M Hughes; T Eisen; M Gore
Journal:  Br J Radiol       Date:  2009-02-16       Impact factor: 3.039

10.  Prognostic stratification of localized renal cell carcinoma by tumor size.

Authors:  Jens Bedke; Maria Pritsch; Stephan Buse; Hildegard Jakobi; Karl-Heinz Elsaesser; Sascha Pahernik; Axel Haferkamp; Markus Hohenfellner
Journal:  J Urol       Date:  2008-05-15       Impact factor: 7.450

View more
  1 in total

1.  Kidney-specific cadherin correlates with the ontogenetic origin of renal cell carcinoma subtypes: an indicator of a malignant potential?

Authors:  M Horstmann; L M Geiger; U Vogel; H Schmid; J Hennenlotter; U Kuehs; A S Merseburger; S Kruck; A Stenzl; J Bedke
Journal:  World J Urol       Date:  2011-09-18       Impact factor: 4.226

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.